Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multi-omics analysis at epigenomics and transcriptomics levels reveals prognostic subtypes of lung squamous cell carcinoma

7 Feb 2020

Abstract excerpt

In this study, we identified prognostic biomarkers for lung squamous cell carcinoma (LUSC) by integrating multiple sets of DNA copy number variants (CNV) and methylation variant (MET) data, and performing qPCR and immunohistochemical identification. We examined the expression of CNV and MET in 368 LUSC patients. Gene expression associated with DNA copy number or DNA methylation was identified and four LUSC gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to Epigenetics and DNA Methylation
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32036209
DOI: 10.1016/j.biopha.2020.109859

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multi-omics analysis at epigenomics and transcriptomics levels reveals prognostic subtypes of lung squamous cell carcinomaPMID 32036209Read ↗

Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinomaSemantic proximity Read ↗

Comprehensive Analysis of Epigenetic Alternations of MicroRNA and DNA Methylation Contribute to Gene Expression and Prognosis in Lung Squamous Cell CarcinomaSemantic proximity Read ↗

Molecular Subtypes Based on DNA Methylation Predict Prognosis in Lung Squamous Cell CarcinomaSemantic proximity Read ↗

Development and validation of a novel immune-related prognostic signature in lung squamous cell carcinoma patientsSemantic proximity Read ↗

Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancerSemantic proximity Read ↗

Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell CarcinomaSemantic proximity Read ↗

Integration of multi-omics profiling reveals an epigenetic-based molecular classification of lung adenocarcinoma: implications for drug sensitivity and immunotherapy response predictionSemantic proximity Read ↗

Comprehensive profiling of genomic and transcriptomic differences between risk groups of lung adenocarcinoma and lung squamous cell carcinomaSemantic proximity Read ↗

Comprehensive genomic characterization of squamous cell lung cancers.Semantic proximity Read ↗

Multidimensional characterization of the tumor microenvironment profiles in lung squamous cell carcinoma.Semantic proximity Read ↗

A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma PrognosisSemantic proximity Read ↗

The tumor environment immune phenotype of LUSC by genome-wide analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.